These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8359898)

  • 21. Effects of IL-12 on helper T cell-dependent immune responses in vivo.
    McKnight AJ; Zimmer GJ; Fogelman I; Wolf SF; Abbas AK
    J Immunol; 1994 Mar; 152(5):2172-9. PubMed ID: 7907633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans.
    Romani L; Puccetti P; Mencacci A; Cenci E; Spaccapelo R; Tonnetti L; Grohmann U; Bistoni F
    J Immunol; 1994 Apr; 152(7):3514-21. PubMed ID: 7908304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans.
    Mencacci A; Del Sero G; Cenci E; d'Ostiani CF; Bacci A; Montagnoli C; Kopf M; Romani L
    J Exp Med; 1998 Feb; 187(3):307-17. PubMed ID: 9449711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis.
    Farah CS; Elahi S; Pang G; Gotjamanos T; Seymour GJ; Clancy RL; Ashman RB
    Infect Immun; 2001 Oct; 69(10):6110-8. PubMed ID: 11553549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta.
    Schmitt E; Hoehn P; Huels C; Goedert S; Palm N; Rüde E; Germann T
    Eur J Immunol; 1994 Apr; 24(4):793-8. PubMed ID: 7908633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local and systemic immune response to inactivated Candida albicans in mice.
    Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
    Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1993 Oct; 61(10):4202-7. PubMed ID: 8406809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.
    Scharton TM; Scott P
    J Exp Med; 1993 Aug; 178(2):567-77. PubMed ID: 8101861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
    Scharton-Kersten T; Afonso LC; Wysocka M; Trinchieri G; Scott P
    J Immunol; 1995 May; 154(10):5320-30. PubMed ID: 7730635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry.
    Klein SA; Dobmeyer JM; Dobmeyer TS; Pape M; Ottmann OG; Helm EB; Hoelzer D; Rossol R
    AIDS; 1997 Jul; 11(9):1111-8. PubMed ID: 9233457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initiation of T-helper cell immunity to Candida albicans by IL-12: the role of neutrophils.
    Romani L; Bistoni F; Puccetti P
    Chem Immunol; 1997; 68():110-35. PubMed ID: 9329219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection.
    Rottenberg M; Cardoni RL; Andersson R; Segura EL; Orn A
    Scand J Immunol; 1988 Nov; 28(5):573-82. PubMed ID: 2463664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of T cell cytokines in resistant and susceptible mice infected with virulent Brucella abortus strain 2308.
    Fernandes DM; Jiang X; Jung JH; Baldwin CL
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):193-203. PubMed ID: 9116636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of IFN-gamma in immune responses to Candida albicans infections.
    Gozalbo D; Maneu V; Gil ML
    Front Biosci (Landmark Ed); 2014 Jun; 19(8):1279-90. PubMed ID: 24896350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
    Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
    Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.
    Sypek JP; Chung CL; Mayor SE; Subramanyam JM; Goldman SJ; Sieburth DS; Wolf SF; Schaub RG
    J Exp Med; 1993 Jun; 177(6):1797-802. PubMed ID: 8098733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-4-producing NK T cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells.
    Leite-De-Moraes MC; Moreau G; Arnould A; Machavoine F; Garcia C; Papiernik M; Dy M
    Eur J Immunol; 1998 May; 28(5):1507-15. PubMed ID: 9603455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.